Rescan 700, Callisto Eye
Tomography, Optical Coherence. 510(k) K141844, from Carl Zeiss Meditec, AG (Dublin, CA). Product code OBO, class 2.
As of Nov 19, 2026, K141844 is an FDA 510(k) held by Carl Zeiss Meditec, AG, substantially equivalent on Nov 18, 2014 after 133 days, with no recalls tied to it in FDA's recall database.
- Review time: 133 days
- Recalls: 0
- Cited as a predicate by: 2 devices
FOR FDA USE ONLY Concurrence of Center for Devices and Radiological Health (CDRH) (Signature) PSC Publishing Services (301) 443-6740 EF Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement on last page.
- Cirrus PhotoK112184 · Carl Zeiss Meditec, Inc. · Jun 18, 2012
- Callisto EyeK123464 · Carl Zeiss Meditec, AG · Mar 5, 2013
- CALLISTO eyeK180858 · Carl Zeiss Meditec, AG · Jun 27, 2018
- RESCAN 700, CALLISTO eyeK180229 · Carl Zeiss Meditec, AG · Jan 11, 2019
- AnterionK261019 · Heidelberg Engineering GmbH · Sep 11, 2026
- SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleK253837 · Heidelberg Engineering GmbH · May 7, 2026
- Unity DX (Udx)K252633 · Cylite Pty. , Ltd. · Dec 23, 2025
- Tomey Cornea/Anterior Segment OCT (CASIA2)K250553 · Tomey Corporation · Jul 18, 2025
- SPECTRALIS HRA+OCT and variantsK250868 · Heidelberg Engineering GmbH · May 12, 2025
- AnterionK240924 · Heidelberg Engineering GmbH · Dec 13, 2024
- SPECTRALIS with Flex ModuleK241163 · Heidelberg Engineering GmbH · Oct 11, 2024
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2); IMAGEnet6 Ophthalmic Data SystemK241081 · Topcon Corporation · Jul 17, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 8, 2014
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files